Effects of TSLPR Blocking on Allergen-Induced Airway Inflammatory Responses

GARG Hari G
DOI: https://doi.org/10.3969/j.issn.1674-6449.2009.01.003
2009-01-01
Health Research
Abstract:Objective To define the role of Thymic stromal lymphopoietin receptor (TSLPR) in allergen-primed airway inflammatory responses, and to investigate the possibility of alleviating allergic disorders by locally inhibiting TSLPR in an asthmatic mice model. Methods In the anti-TSLPR antibody or isotype-immunoglobulin pretreated, ovalbumin (OVA)-primed mice, the airway infiltrated cells were fractioned and counted, and histologic analysis of lung tissues was conducted by staining with hematoxylin and eosin (H&E) and periodic acid Schiff (PAS) respectively. Also the levels of proinflammatory cytokines in bronchoalveolar lavage (BAL) were analyzed by ELISA. The effects of TSLPR inhibition on allergen-initiated responses were further evaluated by assessing the migratory ability and the maturation of OVA-induced dendritic cell (DC). Results Application of Anti-TSLPR antibody before OVA sensitization significantly decreased mucus production and infiltrated eosinophils and lymphocytes in asthmatic mice, together with a remarkable reduction of IL-4, IL-5 levels in BAL. As a mechanism of this effect, neutralization of TSLPR inhibited the maturation and migration of DCs in response to allergen stimulation. Conclusion Blockade of TSLPR-mediated signaling alleviated the allergic airway inflammation, representing a novel strategy in treating airway atopic disorders.
What problem does this paper attempt to address?